|Bid||3.220 x 0|
|Ask||3.250 x 0|
|Day's Range||3.480 - 3.540|
|52 Week Range||1.720 - 4.100|
|PE Ratio (TTM)||9.06|
|Forward Dividend & Yield||0.16 (7.44%)|
|1y Target Est||3.59|
Feb 12 (Reuters) - Central China Real Estate Ltd: * JANUARY CONTRACTED SALES OF RMB1,673 MILLION Source text for Eikon: Further company coverage:
Companies such as Central China Real Estate and Shanghai Fudan-Zhangjiang Bio-Pharmaceutical have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance theirRead More...
Jan 29 (Reuters) - Central China Real Estate Ltd: * GROUP EXPECTS TO RECORD AN INCREASE IN PROFIT ATTRIBUTABLE OF NO LESS THAN 50 PCT FOR FY * EXPECTED RESULT DUE TO INCREASE IN TURNOVER Source text ...
Jan 8 (Reuters) - Central China Real Estate Ltd: * IN DECEMBER 2017, GROUP ACHIEVED PROPERTY CONTRACTED SALES OF RMB4,763 MILLION Source text for Eikon: Further company coverage: (firstname.lastname@example.org)...
High growth companies such as Precision Tsugami (China) and Essex Bio-Technology has a positive future outlook in terms of their returns, profitability and cash flows. The prospects of these companiesRead More...
Dec 5 (Reuters) - Central China Real Estate Ltd: * IN NOVEMBER GROUP ACHIEVED PROPERTY CONTRACTED SALES OF RMB2,798 MILLION, UP 53.9% Source text for Eikon: Further company coverage:
Rating Action: Moody's downgrades Central China's senior unsecured ratings to B1. Global Credit Research- 04 Dec 2017. Hong Kong, December 04, 2017-- Moody's Investors Service has downgraded Central China ...
Central China Real Estate's Hu Baosen said oversupply of housing units in second- and third-tier citing in China is not a bubble.